Background Health Technology Assessment (HTA) is a multidisciplinary field focusing on the medical, social, ethical and economic implications

of health technologies to provide decision-makers with timely, accurate and sound evidence-based information. The benefits of HTA include reducing uncertainty and risks in patient outcomes, cost-effectiveness to the government and the Department of Health, proper targeting of health services and ensuring the safety and efficacy of medical devices.

Contact Information Ms. Marian Valera e-mail: mvalera@aim.edu Phone: +632 8924011 loc. 2073

Goal The AIM Dr. Stephen Zuellig Center for Asian Business In the Philippines, there has been a resounding need for a tool Transformation aims to create a critical mass of HTA that will aid in the assessment of health products and procedures practitioners who will collaborate with government agencies, for their adoption into the Philippine health care system. Recent health care industry players, and the international HTA network legislation such as the Food and Drugs Administration Act of to further promote the importance of HTA as an evidence-based 2009 and the amendments proposed for the National Health tool to support health policy. Customized courses are designed Insurance Program requires the use of policy tools that ensure to develop the skills of participants in benefit assessment cost-effectiveness while promoting access and quality. Health (Biostatistics, clinical epidemiology, patient-relevant outcomes, Technology Assessment (HTA) is an integral component for and risk-benefit assessment), economic evaluation (Costing, assessing health products and procedures for procurement and cost-effectiveness analysis, pharmacoeconomic modeling, registration purposes, in the selection of products for the budget impact analysis, resource allocation), and the application national formulary or technologies for PhilHealth benefit of ethical, legal and social implications in health policy and packages and reimbursements. market access research.

Course Design
Date 23 April Lecture Introduction to Health Technology Assessment By the end of the course, participants are expected to: 1. Familiarize themselves with the key elements, methods and language of Health Technology Assessment and its application to the Philippine/Asian context. 2. Gain a better understanding of basic HTA disciplines, including benefit assessment, economic evaluation, and the ethical, legal and social implication. 3. Apply the use of HTA reports in the countrys health care system by reviewing the practical steps involved in development and utilization of HTA in different countries. 1. 2. 3. Gain a better knowledge of the key terminology and issues involved in pricing decisions and the principles of reimbursement methodologies. Understand recent pharmaceutical spending patterns, trends and costcontainment measures. Appraise the pricing and reimbursement systems in other Asian countries/regions (e.g. Taiwan, South Korea, Thailand, Australia and China Mainland). Understand evaluation design issues in terms of collecting primary economic data in clinical trials, including statistical considerations (e.g.

24 April

Pharmaceutical/Biotech Pricing and Reimbursement Methodologies

25 April

Patient Registries

1.

2. 3. 4. 5.

univariate and multivariate analysis of data, sample size and power calculations). Understand safety and clinical objectives, as well as regulatory trends and requirements. Understand the advantages and disadvantages of patient registry versus other real world data collection. Develop data collection sheets and protocols. Learn management issues, including creating effective partnerships with patient-oriented organizations and facilitating long-term program operations. Familiarize themselves with the foundations of statistical estimation and testing of hypothesis. Perform regression techniques to correlate between variables. Learn the elements of Bayesian statistics and its application to health economics and outcomes research, specifically on clinical trials and costeffectiveness analyses. Understand the basics of probabilistic sensitivity analysis using Montecarlo simulation and the bootstrap method. Generate and utilize different Pharmacoeconomics/health economic models and techniques through practical demonstrations and/or cases. Perform cost-effectiveness analysis on different interventions, such as drugs, devices and clinical services. Practice different pharmacoeconomic models and techniques. These include cost-minimization, cost-of-illness, cost-effectiveness, cost-benefit, and cost-utility analysis; sensitivity analysis, and discounting. Determine the economic impact of clinical outcomes. Track and assign costs to different types of health care resources used.

26 April

Statistical Methods for Pharmacoeconomics & Outcomes Research

1. 2. 3.

4.

27 April

Introduction to Health Econonomic/ Pharmacoeconomic Evaluations

1. 2. 3.

4. 5.

Participants The primary target audiences for this course are:

Senior and mid-level policy makers and implementers from the government (e.g. Department of Health, PhilHealth, Food and Drugs Administration, etc.) Health regulators Hospital administrators Faculties, students, and researchers involved in health policy Marketing analysts from the pharmaceutical and medical devices industry Health sector managers working with the private sector International organizations/development partner representatives

benefit assessment, economic evaluation and social implication studies. Participants will learn the elements of patient registries, medical statistics, cost-effectiveness, costbenefit and cost-utility analysis and their significance in health policy and marketing studies. Training Contribution The course requires a contribution of 25,000 PhP to the AIM Scientific Research Foundation. This contribution will cover tuition, course materials, meals, and other expenses related to the conduct of the course. For institutions that will send at least 3 persons, a reduced contribution of 22,000 PhP per person is offered. Deadline of Application To secure a place for the training, applicants should complete the application form and return it to the organizers no later than 17 April 2012. Venue AIM Conference Center Manila (ACCM) Benavidez cor. Trasierra Sts. Legaspi Village, Makati City,1260 Philippines http://www.accm.aim.edu
The Center can assist you if you would like to reserve for accommodation at the ACCM hotel.

Team of Lecturers The faculty for the HTA course will be formed by a team of experts from the International Society of Pharmacoeconomics and Outcomes Research (ISPOR) and from leading international institutions on pharmacoeconomics and health policy research. Course Approach The 5-day course takes an applied approach to teaching health economics and Pharmacoeconomics methods by combining a series of lectures and workshops. Training materials will cover key methodologies in understanding